Get your free Locked4Kids sample!

Locked4Kids Wallet Box and Carton samples
Experience our new Wallet Box or trusted Carton first hand!
  • Child resistant, senior friendly
  • ISO/EN 8317 and F=1 US16 CFR 1700.20 certified
  • Available in a range of sizes and applications
Request your free sample now! Leave your name and e-mail. Samples are sent without any costs.
Provide your name and e-mail to get contacted for delivery details
Thank you!

Your sample request has been sent! You'll get a confirmation at the provided email address.
We're sorry. Something went wrong while submitting the form.
Sample request
Icon for free sampleClose icon

CPSC child resistant packaging rules, a guide to US compliance

Gianni Linssen
Written by
Gianni Linssen
/ Published on
August 12, 2026
Learn how CPSC child resistant packaging rules work with FDA and state requirements, and which test reports and documents your US pack needs.

In the United States, the main federal rules for child-resistant packaging come from the CPSC under the Poison Prevention Packaging Act (PPPA). The core rule set is 16 CFR Part 1700. The FDA can also regulate the drug or supplement itself, and state regulations can add another layer, especially concerning cannabis products. This means the answer to who regulates child-resistant packaging is often shared across different authorities, yet each authority plays a distinct role. For teams working with medicines, cannabis products, or nutraceuticals, the CPSC child-resistant packaging rules are the starting point for the package requirements themselves.

• The CPSC governs special packaging under the PPPA, and 16 CFR Part 1700 serves as the primary federal rule.

• An FDA review does not replace CPSC child-resistant packaging testing when both sets of rules apply.

• State cannabis rules can add local requirements, but they do not replace separate federal testing mandates.

• The domestic manufacturer or importer holds the ultimate compliance responsibility, including maintaining required documents such as the General Certificate of Conformity (GCC) where applicable.

• Supplier test data is helpful, but it must match the exact package design you plan to ship.

What the CPSC child-resistant packaging rules cover in the United States

The US regulatory system is easier to understand when separated into layers. The CPSC administers the PPPA, and the main federal rules for special packaging are found in 16 CFR Part 1700. In simple terms, special packaging refers to a design that is difficult for young children to open or access within a reasonable timeframe, yet remains fully usable for normal adults. This forms the core of CPSC child-resistant packaging at the federal level. If you want a broader background before you compare formats, our guide to CR packaging explains the main options in plain language.

For covered products, these constitute the main CPSC packaging requirements for the container itself. In practice, this often matters for prescription and over-the-counter medicines, and it can also matter in projects involving nutraceuticals or cannabis products. Many readers search for who regulates child-resistant packaging because they want one clear answer before they approve a pack. The practical answer is that the CPSC controls the special packaging rule, while other authorities may control other parts of the product. If you are moving from rule review into implementation, our US child-resistant packaging requirements page provides a useful next step.

How CPSC child-resistant packaging rules differ from FDA review

The CPSC's role under the PPPA

The CPSC governs child-resistant packaging requirements for products covered by the PPPA. When development teams discuss federal child-resistant packaging rules, this is typically what they are referring to. The agency's focus remains entirely on the package and whether it meets the special packaging standards for the covered product.

The FDA's role in drug and supplement regulation

The FDA regulates drugs and supplements within its own specific jurisdiction. This oversight can include the product itself, its labeling, stability, and a container closure review. However, understanding FDA versus CPSC packaging is an important distinction, because an FDA review of a container closure system is not the same as a CPSC child-resistant packaging test. A container closure system involves the components that hold and seal the product, but an FDA review of these parts does not automatically prove PPPA compliance.

Why both layers can apply at the same time

One agency's approval does not replace the other's. A drug can undergo FDA review and still require packaging that meets CPSC special packaging rules. This is why teams should map out product rules, packaging rules, and any state regulations separately. By doing so, they can avoid missed steps and false assumptions during the final approval or product launch.

Who holds responsibility under CPSC child-resistant packaging rules

The finished-product company’s duty

The company that places a regulated, finished product on the US market retains its own conformity responsibility. In many cases, this refers to the domestic manufacturer or importer. That company cannot pass its entire duty onto the packaging supplier, as the finished-product company is ultimately the one selling or importing the packaged goods. This represents the practical side of child-resistant packaging liability. The company must know which rules apply, what test evidence supports the final packaging, and which internal records it must keep.

What the packaging supplier can provide

A packaging supplier can provide protocol reports, design details, and test data that support a technical review. This information proves useful because it helps procurement, engineering, and regulatory teams compare the actual package against the available evidence. However, supplier evidence does not replace the finished-product company's own required documentation. You should ask for the report covering the exact package design you plan to ship, because a broad claim like a 'child-resistant carton' is far too general. When reviewing a defined format, our child-resistant carton page shows an excellent example of a specific design that can be assessed against an actual blister and carton setup.

What the General Certificate of Conformity means

The General Certificate of Conformity, or GCC, is frequently misunderstood. Simply put, it is the document stating that a product complies with applicable consumer product safety rules, based on proper testing or a reasonable testing program. This represents a key part of General Certificate of Conformity packaging procedures. CPSC guidance explicitly places this duty on the domestic manufacturer or importer whenever a GCC is required. Therefore, the finished-product company must create and maintain this document, even while supplier data may support the overall file.

How to document compliance with CPSC child-resistant packaging rules

Match the evidence to the exact tested design

The most important purchasing rule is simple: do not approve a generic child-resistant claim. Instead, approve a defined package design backed by evidence that matches the exact setup you intend to ship. This is why child-resistant packaging certification should always be reviewed at the design level, rather than as a broad promise covering an entire product group. In practice, the blister size, materials, dimensions, carton structure, and opening mechanism should all perfectly match the report. This is where the CPSC child-resistant packaging rules become highly practical, because formal proof applies to a specifically tested design and not to a loose product description.

We see this clearly during packaging review work, as even minor design changes can significantly affect performance. For example, one tested design might open only when two diagonal push points are pressed simultaneously. Another tested design could be an all-paper Wallet Box holding up to three blister strips. Both tested designs run smoothly on standard cartoning lines at normal speeds, and both possess US F=1 evidence as well as European ISO 8317 evidence for their tested configurations. Even so, the customer still retains the final regulatory responsibility for the finished, packaged product.

When older test data can still be relevant

Older test data can still be highly useful, provided the package being shipped remains identical to the original tested design. There is no fixed expiration date that automatically invalidates a report simply because it is old. However, any alteration in material, dimensions, opening features, pack count, or pack setup can quickly diminish the value of older data. Therefore, teams should carefully review any design changes before relying on historical reports.

What US test evidence looks like

In the US, development teams frequently ask for the exact child-resistant test results for the specific design under review. For tested designs within our range, this typically includes US F=1 evidence. This evidence remains entirely separate from European ISO 8317 evidence, as the two markets utilize fundamentally different systems. Consequently, one report should never be treated as a direct substitute for the other. When you work under CPSC child-resistant packaging rules, your US market configuration must be checked against the correct US test evidence.

State rules and cannabis: where federal and local requirements meet

Why cannabis needs a market-by-market check

Cannabis products provide the clearest example of this state-level regulatory layer. State laws may enforce their own packaging conditions or simply reference broader child-resistant packaging standards. Consequently, cannabis child-resistant packaging rules should always be verified on a market-by-market basis. A targeted internal checklist detailing only the states where you actively operate is usually far more practical than a massive guide covering all jurisdictions, especially since local rules change frequently and granular details matter deeply during launch planning.

Why state rules do not replace federal testing

A state rule never replaces a separate federal requirement when the federal rule also applies. For instance, a state simply referencing child-resistant packaging does not automatically make an ISO 8317 certification a valid substitute for a federal 16 CFR test. Teams should therefore treat state and federal requirements as entirely separate hurdles, documenting compliance for both whenever needed. This diligent approach helps reduce approval gaps and prevents costly import issues later down the line.

When CPSC child-resistant packaging rules move into enforcement

What can trigger reporting duties

Packaging issues transition into enforcement territory when available information reasonably supports a concern that a product fails an applicable CPSC rule or poses a related safety risk. This is the crucial tipping point where PPPA enforcement and child-resistant packaging enforcement become highly tangible business issues. Customer complaints, internal test findings, field data, or any evidence of package failure can all trigger this scrutiny. Maintaining excellent records helps immensely, as they clearly show which design was originally used, what changes were implemented, and what specific evidence supported those business decisions.

What happens after a report

Filing a report to the CPSC does not automatically trigger a product recall. Instead, the CPSC reviews the facts and decides whether corrective action is actually required. In some cases, the agency may simply ask questions, review your technical file, and determine the next appropriate step based on that review. This is exactly why packaging recall requirements must be understood as part of a much wider compliance process. Clear historical records and design-specific testing evidence make the entire process significantly easier to manage.

Buying child-resistant packaging with the right evidence

For procurement teams and packaging engineers, the primary lesson is abundantly clear. Do not purchase based on a generic claim. Instead, buy a defined package design backed by evidence that matches the actual configuration you will ship. That remains the only reliable way to connect a safety claim to the physical pack. Our tested designs include a traditional carton format as well as an all-paper Wallet Box. Both are perfectly designed for standard cartoning equipment running at normal speeds; nonetheless, the testing evidence must still closely match your exact blister, carton, and opening setup.

If your current project extends beyond the child-resistant pack itself, Ecobliss Pharma and our wider group can also support broader packaging development, contract packing with serialization, and even packaging machine planning where necessary. However, that broader work remains entirely separate from our specific role as your child-resistant packaging supplier, meaning the finished-product company strictly retains its own final approval and compliance duties.

Check your planned blister and carton against the available test report

A highly practical next step is to carefully compare your planned blister and carton specifications against the available test report prior to final approval. Double-check the exact opening method, the physical dimensions, the board or paper structure, the blister layout, and the overall pack setup. Then, confirm exactly which company will hold the finished-product documents and the GCC, where required. If you want to review a real-world configuration with us, you can discuss your packaging specification with our team and request a sample for a hands-on evaluation. This approach keeps the entire process firmly focused on concrete evidence and the exact pack you actually plan to ship.

Simple regulatory map for teams

The breakdown below offers a quick view of the main US regulatory layers, helping your team separate authority, evidence, and document ownership well before final pack approval.

CPSC: Regulates special packaging under the PPPA, heavily leaning on 16 CFR Part 1700. CPSC approval does not replace an FDA review. Furthermore, the finished-product company typically maintains the compliance file and any required conformity documents.

FDA: Regulates drugs and supplements within its own jurisdiction, handling product and labeling matters. FDA oversight does not replace CPSC child-resistant packaging testing whenever that packaging rule applies. Therefore, product teams should keep all FDA-related records separate.

State authority: Can impose additional local packaging rules, especially regarding cannabis products. State rules absolutely do not replace separate federal testing requirements. Accordingly, companies should maintain a market-specific rule check for every state in which they actively operate.

Practical review points before approval

Use this short checklist before you officially sign off on a child-resistant pack, because even a small mismatch between your test evidence and your shipped package can create entirely avoidable risks later on.

Exact design: Confirm that the tested pack perfectly matches the specific blister, carton, materials, dimensions, and opening method you plan to ship.

Applicable rules: Confirm whether the PPPA, the FDA, or any state cannabis rules apply to your product and target market.

Test evidence: Request the official protocol report for the exact design in question, and critically review whether any recent design changes might affect its relevance.

Document ownership: Clearly confirm who will maintain the finished-product file alongside the General Certificate of Conformity, where required.

Change control: Thoroughly review any updates regarding materials, pack count, opening features, or line setups before blindly relying on older reports.

FAQ

Who regulates child-resistant packaging in the US? For products legally covered by the PPPA, the CPSC regulates the child-resistant packaging requirements. Meanwhile, the FDA regulates drugs and supplements within its own area, and state authorities can implement local rules, especially concerning cannabis products.

Is an FDA review enough for a child-resistant drug pack? No. An FDA review does not replace a standard CPSC child-resistant packaging requirement. Both regulatory layers must be reviewed separately whenever both apply.

Who must keep the General Certificate of Conformity? CPSC guidance firmly places that duty on the domestic manufacturer or importer whenever a GCC is required. A packaging supplier can definitely support the file with relevant test data, but the finished-product company ultimately retains its own strict documentation duties.

Can supplier test data be used for our finished product? Yes. Supplier test data can certainly support your compliance process if it directly covers the exact package design you intend to ship. However, it does not magically replace your own finished-product documentation or final approval work.

Do state cannabis rules replace federal CPSC testing? No. While state rules can certainly add extra requirements, they never replace a separate federal testing mandate when that federal rule also legally applies.

Request a free sample now!

Single carton Locked4Kids
Do you want to experience first hand the usability and quality of our packaging solutions? We'll send you one!
Request the free sample!
This might also interest you:

Contact the team

Our team is the perfect combination of knowledge, experience and eagerness. Contact them by giving them a call or sending a message to let them know what a convenient time is for them to call you.
Jaime Wauben

Jaime Wauben

+31615446090
Timo Kubbinga

Timo Kubbinga

+31627348895
Gianni Linssen

Gianni Linssen

+31625517974

Or send a message

Thank you! Your submission has been sent! We'll contact you soon.
Oops! Something went wrong while submitting the form.
Locked4Kids B.V.
Edisonweg 11
6101 XJ Echt, The Netherlands
KVK: 60610182
+31 475 390 550
Follow us on
Icon LinkedIn
Ecobliss is FSC® certified with license number C194323
© 2025 Ecobliss Group
Site by
Merkmotief